Abstract:Importance: Mild Behavioral Impairment (MBI), characterized by neuropsychiatric symptoms that precede cognitive decline, may reflect early neurodegenerative changes. Identifying structural brain changes associated with MBI could enhance early risk stratification and intervention. Objective: To investigate the association between MBI symptoms and cortical thinning as a structural marker of neurodegeneration in a Southeast Asian cohort. Design, Setting, and Participants: This cross-sectional study analyzed baseline data from the Biomarkers and Cognition Study, Singapore (BIOCIS), a five-year longitudinal study initiated in 2023 that recruits community participants across Singapore. Cross-sectional data from 1,145 participants (mean age: 62 SD 13.5 years; 53% female) with normal cognition, subjective cognitive decline (SCD), or mild cognitive impairment (MCI) were included. Main Outcomes and Measures: Behavioral symptoms were assessed using the Mild Behavioral Impairment Checklist (MBI-C), which captures neuropsychiatric symptoms across five domains: decreased motivation, affective dysregulation, impulse dyscontrol, social inappropriateness, and abnormal perception or false beliefs. Cortical thickness was measured using T1-weighted MRI, processed through FreeSurfer. The primary outcome was the relationship between MBI-C total and subdomain scores and cortical thinning. Results: Higher MBI-C Belief scores were associated with cortical thinning in the right hemisphere (coefficient = -0.0177; 95% CI: -0.0342 to -0.0012; P = .035). Significant thinning was observed in specific regions: posterior banks of the superior temporal sulcus (coefficient = -0.020; 95% CI: -0.037 to -0.004; P = .013), fusiform gyrus (coefficient = -0.021; 95% CI: -0.037 to -0.005; P = .009), superior temporal gyrus (coefficient = -0.020; 95% CI: -0.037 to -0.002; P = .025), temporal pole (coefficient = -0.018; 95% CI: -0.034 to -0.003; P = .021), and transverse temporal gyrus (coefficient = -0.020; 95% CI: -0.036 to -0.004; P = .014). After false discovery rate correction, the associations in the posterior banks of the superior temporal sulcus, fusiform gyrus, superior temporal gyrus, and transverse temporal gyrus remained significant (FDR P = .042-.045). In addition to these temporal regions, higher MBI-C Belief scores were significantly associated with cortical thinning in the right postcentral gyrus (coefficient = -0.020; P = .012) and right supramarginal gyrus (coefficient = -0.021; P = .013), which remained significant post-FDR correction (FDR P = .039). The right insula (coefficient = -0.0174; P = .034) showed significant thinning, confirmed by FDR correction (FDR P = .037). Conclusions and Relevance: Higher MBI-C scores are linked to cortical thinning in brain regions essential for memory, spatial orientation, and emotional regulation. These findings support the use of MBI as an early marker of neurodegeneration, helping identify individuals at risk of cognitive decline. Incorporating MBI assessments into clinical practice could guide the triaging of neuroimaging orders, optimizing healthcare resource use.

Unraveling the Potential Underlying Mechanisms of Mild Behavioral Impairment: Focusing on Amyloid and Tau Pathology

An Updated Review Focusing on Alzheimer's Disease

Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer’s disease

Mild Behavioral Impairment Correlates of Cognitive Impairments in Older Adults Without Dementia: Mediation by Amyloid Pathology

Mild behavioral impairment domains are longitudinally associated with pTAU and metabolic biomarkers in dementia‐free older adults

Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer’s disease

Potential benefits of mindfulness-based interventions in mild cognitive impairment and Alzheimer's disease: An interdisciplinary perspective

Mild behavioral impairment linked to progression to Alzheimer's disease and cortical thinning in amnestic mild cognitive impairment

Salience Network Segregation Mediates the Effect of Tau Pathology on Mild Behavioral Impairment

Mild behavioral impairment in prodromal Alzheimer ́s disease and its association with APOE and BDNF risk genetic polymorphisms

Neuropsychiatric symptoms: Risk factor or disease marker? A study of structural imaging biomarkers of Alzheimer's disease and incident cognitive decline

Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer’s disease: a systematic review

Mild behavioral impairment in early Alzheimer's disease and its association with APOE and BDNF risk genetic polymorphisms

Mild Behavioural Impairment as a Clinical Correlate of Early Neurodegeneration

Prevalence of mild behavioural impairment and its association with cognitive and functional impairment in normal cognition, mild cognitive impairment, and mild Alzheimer's dementia

Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal study

Mild Behavioral impairment (MBI) and late-life psychiatric disorders: Differential clinical features and outcomes.

S4: Mild Behavioral Impairment. Assessment, biological and clinical factors in the cognitive impairment continuum

Interactions between mild depressive symptoms and amyloid pathology on the trajectory of neurodegeneration, cognitive decline, and risk of Alzheimer's disease

Multimodal investigation of neuropathology and neurometabolites in mild cognitive impairment and late-life depression with 11C-PiB beta-amyloid PET and 7T magnetic resonance spectroscopy